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EllipsometryThe fusion peptide of Ebola virus comprises a highly hydrophobic sequence located downstream from the
N-terminus of the glycoprotein GP2 responsible for virus–host membrane fusion. The internal fusion peptide of
GP2 inserts into membranes of infected cell to mediate the viral and the host cell membrane fusion. Since the
sequence length of Ebola fusion peptide is still not clear, we study in the present work the behavior of two fusion
peptides of different lengthswhichwere named EBO17 and EBO24 referring to their amino acid length. The second-
ary structure and orientation of both peptides in lipid model systems made of DMPC:DMPG:cholesterol:DMPE
(6:2:5:3)were investigated using PMIRRAS and polarized ATR spectroscopy coupledwith Brewster anglemicrosco-
py. The infrared results showed a structural ﬂexibility of both fusion peptides which are able to transit reversibly
from an α-helix to antiparallel β-sheets. Ellipsometry results corroborate together with isotherm measurements
that EBO peptides interacting with lipid monolayer highly affected the lipid organization. When interacting with a
single lipid bilayer, at low peptide content, EBO peptides insert as mostly α-helices mainly perpendicular into the
lipidmembrane thus tend to organize the lipid acyl chains. Inserted inmultilamellar vesicles at higher peptide con-
tent, EBO peptides are mostly in β-sheet structures and induce a disorganization of the lipid chain order. In this
paper, we show that the secondary structure of the Ebola fusion peptide is reversibly ﬂexible between α-helical
and β-sheet conformations, this feature being dependent on its concentration in lipids, eventually inducing mem-
brane fusion.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The Ebola virus is one of the most virulent pathogens for humans
and primates. It has caused several outbreaks in central Africa in the
past decade and currently no treatments or vaccines are approved yet.
Ebola virus is an enveloped virus that belongs to the ﬁloviridae family.
It causes severe hemorrhagic fever that is often lethal in humans.
Early target cells aremonocytes, macrophages, dendritic cells and hepa-
tocytes then the infection rapidly spreads to the viral organs of the host.
Infection of a target cell by enveloped virus requires fusion between the
viral enveloped and host cell membrane. The membrane fusion process
is a common feature of enveloped viruses and is mediated by a glyco-
protein (GP) that acts as a membrane fusion protein. The Ebola GP is a
class I fusion protein that forms trimeric spikes on the virion surface
[1]. During the maturation of the virion, GP is activated by proteolytic
cleavage into two parts: GP1 and GP2, connected by a disulﬁde bond.holine; DMPG, dimyristoyl-
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tano).
ights reserved.In all the class I fusion protein, the ﬁrst subunit binds to the cell recep-
tors while the second subunit mediates the fusion between viral and
host cellmembranes. For Ebola, the fusion process ismediated by the vi-
rally encoded glycoprotein GP2 that contains a highly hydrophobic se-
quence generally referred as the fusion peptide which initiates the
fusion event by anchoring glycoprotein GP2 to the cell membrane sur-
face. Unlike other class I fusion proteins, the Ebola fusion peptide is lo-
cated within the GP2 structure downstream from the N-terminus. This
conserved peptide sequence is absolutely required for the fusogenic ac-
tivity of the glycoprotein GP2 but its structural and functional determi-
nants remain unknown. Previous studies showed that endosome allows
pH activating cathepsin L and B activities that is required for viral fusion
to occur where GP2 undergoes a subsequent conformational change
exposing the fusion peptide to the host membrane [2–4]. However,
how Ebola fusion peptide binds to the membranes and induces fusion
remains poorly understood.
Several studies about Ebola fusion peptide have been done in differ-
ent conditions and different mimetic membrane environments, partly
leading to inconsistent results. In general, Ebola fusion peptide can
adopt different structures depending on its environment. Moreover,
the exact peptide sequence involved in the fusion, which was initially
predicted by Gallaher et al. [5] is not well deﬁned to date, as numerous
studies used different fusion peptide lengths. Freitas et al. [6] utilized
Ebola fusion peptide composed of 16 amino acids, EBO16 (524–539
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(CD) and nuclear magnetic resonance (NMR). They showed a random
coil–helix transition when they added SDS micelles to an insoluble
water-diluted EBO16 solution. The NMR structure of EBO16 showed
that in the presence of mimetic membranes, the peptide adopts a cen-
tral 310-helix structure stabilized by aromatic interaction between
amino acids Trp8 and Phe12. Suárez et al. [7] used a 17 amino acid se-
quence as fusion peptide (EBOGE: 524–540 from GP2) and also showed
by UV CD spectroscopy structural transition between random-coil in
aqueous buffer and anα-helix structure induced by increasing concen-
tration of TFE. Moreover, they demonstrated by IR spectroscopy that in
association to PC/PI (1:2) vesicles, the fusion peptide undergoes a con-
formational change from anα-helix to an anti-parallel β-structure, pre-
sumably induced by the presence of calcium. In fact, the α-helical
structure seems to be related to the ability of the peptide to induce de-
stabilization of the membrane while the presence of Ca2+ provocated a
conformational transition of the peptide to a β-sheet structure [7–9]. In
a more recent study [10], Freitas et al. suggested that although their
EBO16 fusion peptide adopts a β-sheet structure, it was only able to in-
duce PC:PE:SPM:Chol liposome aggregation but not fusion. They also
showed by experiments of raft aggregation and cell–cell fusion that
EBO16 fusion peptide is able to use lipid raft domains enriched in cho-
lesterol [11] as a target for virus entry into cells. This suggests an impor-
tant role of cholesterol since cholesterol depleted cells have impaired
EBO virus glycoprotein-pseudotype-virion entry and fusion [12]. They
also demonstrated that the fusion peptide EBO16 can induce lipid
mixing of the living Vero cells even in absence of Ca2+. In the same
study, EBO16 was proposed to lie parallel to the membrane anchored
by the aromatic amino acids, Trp8 and Phe12. In another study
conducted by Adam et al. [13], they used a shorter peptide of 11
amino acid long (524 to 534) capable of liposome destabilization and
fusion. They also analyzed its behavior in a hydrophobic/hydrophilic en-
vironment by molecular modeling. They proposed a mechanism where
the peptide is obliquely inserted in the hostmembrane and further able
to destabilize it.
The aim of the present work was to clarify the inconsistencies be-
tween the previously published data and to improve our understanding
of the fusion mechanism by which the Ebola fusion peptide inserts into
lipid membrane. The structural behavior of the individual Ebola fusion
peptide as well as that bound to a lipid membrane model has thus
been investigated using several infrared (IR) spectroscopy techniques:
PMIRRAS at the air/water interface of the peptides alone and inserted
into lipid monolayers and ATR spectroscopy of peptides inserted in bi-
and multi-bilayers. Investigations at the air/water interface were com-
bined with ellipsometric measurements to analyze the morphology of
the layers. The peptide orientation given by IR experimental results
were analyzed using spectral simulation. Two peptide sequences were
studied: the 17 (residues 524–540, EBO17) and the 24 (residues 524–
547, EBO24) amino acid consensus sequences.2. Materials and methods
2.1. Lipids and peptides
Lipids (DMPC, DMPG, cholesterol and DMPE) were purchased from
Sigma. The Ebola fusion peptides EBO17: GAAIGLAWIPYFGPAAE
and EBO24: GAAIGLAWIPYFGPAAEGIYTEGL were purchased from
GenScript (Piscataway, USA). EBO17 and EBO24 were solubilized
in hexaﬂuoroisopropanol (HFIP) from Sigma at micromolar con-
centrations. Peptide concentrationswere calculated fromthe absorbance
at 280 nm using a molar extinction coefﬁcient ε280 of 7000 M−1·cm−1
for EBO17 and ε280 of 8400 M−1·cm−1 for EBO24. The molar extinction
coefﬁcient of the peptides has been determined using the formula
ε280nm = 5600 × nW + 1400 × nYwhich takes into account the individ-
ual extinction coefﬁcient of the amino acids W and Y.2.2. Film formation and surface pressure measurements
Monolayer experiments were performed on a computer-controlled
Langmuir ﬁlm balance (Nima Technology, Coventry, England). The rect-
angular trough and the barrier weremade of Teﬂon. The surface pressure
(π)wasmeasured by theWilhelmymethod using a ﬁlter paper plate. The
trough was ﬁlled with a saline solution (150 mM NaCl, pH 5.6) using
ultra pure water (MilliQ, Millipore). The experiments were carried out
at 22 ± 2 °C. Pure peptide ﬁlms were obtained by spreading of few μl
of HFIP peptide stock solutions at the air/water interface. The mixed
lipids/peptides at the deﬁned lipid to peptide ratio, Ri was obtained by
co-spreading of the lipid/peptidemixture at thewater surface. Themono-
layer lipid composition used was DMPC:DMPG:cholesterol:DMPE
(6:2:5:3). After ~15 min of stabilization, the ﬁlmwas slowly compressed
up to 40 mN·m−1 and decompressed at the same rate speed than during
the compression (8 Å2·molecule−1·min−1).
2.3. PMIRRAS spectroscopy
PMIRRAS spectra were recorded on a Nicolet Nexus 870 spectrometer
equipped with a photovoltaic HgCdTe detector cooled at 77 K. Spectra
were obtained by performing 800 scans at a resolution of 8 cm−1. Brieﬂy,
PMIRRAS combines FT-IR reﬂection spectroscopy with fast polarization
modulation of the incident beam between parallel (p) and perpendicular
(s) polarizations. The differential reﬂectivity spectrum is obtained using a
two-channel processing signal. To remove the contribution of liquid
water absorption and the dependence on Bessel functions, themonolayer
spectra are divided by that of the subphase. With an incidence angle of
75°, transition moments preferentially oriented in the plane of the inter-
face give intense and upward oriented bands, while perpendicular ones
give weaker and downward oriented bands [14].
2.4. ATR spectroscopy of the fusion peptide inserted in a lipid bilayer
Small unilamellar vesicles (SUV) composed of DMPC:DMPG:
cholesterol:DMPE (6:2:5:3)were prepared pure ormixedwith the fusion
peptide at a deﬁned molar ratio, Ri. For pure lipid SUV, lipids were ﬁrst
dissolved in chloroform and mixed at the desired ratio. The solvent was
then evaporated giving a lipid ﬁlm. SUV were then prepared by tip soni-
cation after direct hydration of the lipid ﬁlm with a solution of D2O con-
taining 150 mM NaCl. For the preparation of the SUV containing the
mixed fusion peptide/lipids, the fusion peptide powder is ﬁrst dissolved
in HFIP then mixed with the lipids in chloroform at the desired ratio.
Solvents were evaporated before hydration by D2O and tip sonication
for SUV formation. SUV were then burst on a germanium ATR crystal to
form a single bilayerwhich is controlled by themeasurement of the abso-
lute IR intensity.
ATR spectra were recorded on a Nicolet 6700 spectrometer Thermo
Scientiﬁc equippedwith aMCT detector cooled at 77 K. Since ATR spec-
troscopy is sensitive to the orientation of the structures [15–17], spectra
were recorded with parallel (p) and perpendicular (s) polarizations of
the incident lightwith respect to theATRplate. 400 scanswere recorded
at a resolution of 8 cm−1. All the orientation information is then
contained in the dichroïc ratio RATR = Ap/As, where Ai respectively rep-
resents the absorbance of the considered band at p or s polarization of
the incident light.
2.5. Ellipsometric measurements
The morphology of pure peptides or mixed lipids with the peptides
was observed at the air/water interface using an ellipsometer iElli2000
microscope (NFT, Göttinger, Germany) mounted on a Langmuir trough.
The microscope was equipped with a doubled frequency Nd:Yag laser
(532 nm, 50 mW), a polarizer, a compensator, an analyzer and a CCD
camera. The spatial resolution of the pictures with the 10× magniﬁca-
tion lens was about 2 μm and the image size was 600 × 450 μm. For
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dence angle close to the Brewster angle (54.6°). It operates using the prin-
ciple of a classical null ellipsometer [18]. The ellipsometric angles (Δ,Ψ)
are determined from polarizer and analyzer azimuths at extinction;
Δ andΨ are related to the optical properties of the sample.
In ultra-thin ﬁlm conditions, Δ is proportional to the ﬁlm thickness.
The comparison of the experimental data with a computerized optical
modeling included in the ellipsometer software allowed to provide an
estimation of the ﬁlm thickness when a value of refractive index can
be obtained. Since it is difﬁcult to determine an experimental refractive
index value, we choose 1.50 for the EBO peptides as it was used in a pre-
vious work concerning the fusion peptide FP23 of HIV [19]. Indeed, in
the literature, variations between 1.45 [20] and 1.53 [21,22] can be en-
countered for protein and peptide depending on the amount of water
taken into account. Concerning lipids, anisotropic refractive indices be-
tween 1.44 [23] and 1.50 [24] were reported for DMPC in the literature.
Therefore, we use an intermediate value of 1.46 to perform thickness es-
timations [19].
3. Results
3.1. Morphological and structural study of the fusion peptides EBO17 and
EBO24 at the air/water interface
3.1.1. EBO17 at the air/water interface
The Brewster angle microscope (BAM) images of the pure EBO17
layer at increasing surface pressures from 5 to 20 mN/m (Fig. 1) display
a progressive increase of the averaged normalized gray level until
20 mN/m. Every picture shows a very stable homogeneous surface of
the peptide layer even at low pressures such as 2 mN/m (data not
shown) and the peptide ﬁlm appears brighter during compression.
The thickness of the layer was estimated by ellipsometry using a con-
stant refractive index of 1.50 for the peptide (cf. Materials and
methods section). As the peptide ﬁlm is compressed, estimated thick-
ness increases from 9 Å (Δ = 354.37°, Ψ = 2.42) at 5 mN/m to 14 Å
(Δ = 352.20°, Ψ = 2.42°) at 20 mN/m.
The PMIRRAS spectra at the air/water interface of the EBO17
peptide ﬁlm during compression from 1 to 20 mN/m displayed
well resolved but broad amide I bands between 1600 and 1700 cm−1
and amide II bands centered around 1530 cm−1 (Fig. 2A). At lower sur-
face pressures (below 7 mN/m), the amide I band is mainly centered
around 1652 cm−1 reﬂecting a main content of α-helix. A shoulderFig. 1.BAM images of EBO17alone at the air/water interface. For EBO17: at 5 mN/m, GL = 42, at
GL = 35, at 10 mN/m, GL = 39, at 15 mN/m, GL = 45, at 20 mN/m, GL = 54. Exposition tim
GL: gray level.around 1630 cm−1 also shows a β-sheet contribution and secondary de-
rivative (not shown) displays also contributions around 1642 cm−1 and
1670 cm−1 respectively a characteristic of random and β-turn struc-
tures [16,25,26]. During compression of the peptide ﬁlm (up to
15 mN/m), there is a shift of the position of the main amide I band. The
contribution of the α-helix (around 1652 cm−1) decreases in favor
of two other main contributions centered around 1630 cm−1 and
1690 cm−1 a characteristic of antiparallel β-sheets which become
predominant at 20 mN/m. Since these two contributions display
positive bands, one can assume that antiparallel β-sheets are mainly
oriented ﬂat on the air/water interface plane [27,28].
During decompression down to 10 mN/m, the main component re-
mains centered around 1630 cm−1with a shoulder at 1690 cm−1 reveal-
ing the predominance of β-sheet structures. PMIRRAS spectra at these
intermediate surface pressures also contain shoulder at 1655 cm−1
reﬂecting a small content of α-helix. At lower surface pressure (below
7 mN/m), themainband is centered around1655 cm−1,mainly a charac-
teristic of α-helical structures.
This experiment suggests that EBO17 undergoes a conformational
transition from anα-helix to an antiparallel β-sheet when surface pres-
sure is increased and that this transition is reversiblewhen surface pres-
sure is decreased. This result is conﬁrmed during a second compression/
decompression cycle where the fusion peptide EBO17 reversibly un-
dergoes a transition from α-helix to β-sheet.
3.1.2. EBO24 at the air/water interface
Like EBO17, EBO24 at the air/water interface shows homogeneous
and stable ﬁlms as depicted in Fig. 1. The gray level intensity increases
as the surface pressure rises and the thickness can be estimated by
ellipsometry. EBO24 forms ﬁlm with an estimated thickness of about
10 Å (Δ = 354.29°, Ψ = 2.41°) at 5 mN/m up to 17 Å (Δ = 350.99°,
Ψ = 2.41°) at 20 mN/m.
PMIRRAS spectra of EBO24 at the air/water interface (Fig. 2B) display
a main amide I band around 1653 cm−1 at surface pressures below
15 mN/m showing that EBO24 is mainly structured as an α-helix. An
equivalent of “full width at half maximum” (FWHM) on the main
amide I band can be estimated: FWHM = 74 cm−1 at 15 mN/m and
51 cm−1 at 20 mN/m for EBO17 compared to 51 cm−1 and 45 cm−1
for EBO24 at the same surface pressures. This comparison clearly
shows that the amide I band of EBO24 is thinner compared to the one
of EBO17 showing better folding of EBO24. Then one can assume that
the amide contributions are mainly due to the α-helical structure.10 mN/m,GL = 48, at 15 mN/m, GL = 52, at 20 mN/m,GL = 53. For EBO24: at 5 mN/m,
e for each image was ﬁxed at 1/50 s. Sub-phase: saline solution, 150 mN NaCl, pH 5.6.
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helix axis lying parallel to the interface plane [27,28]. During compres-
sion of the peptide monolayer up to 20 mN/m, there is a shift of the
maximumof themain amide I band to 1630 cm−1with a second contri-
bution at 1690 cm−1 characteristic of antiparallel β-sheet structure of
EBO24. Again, the positive contributions of these two β-sheet bands
allow to propose aﬂat orientation of theβ-sheet structure of thepeptide
with respect to the interface plane. During decompression down to
10 mN/m, the amide I band shifts back to a main contribution at ap-
proximately 1653 cm−1 which is a characteristic of a major α-helical
structure. Then as observed for EBO17, EBO24 undergoes a reversible
structural transition from an α-helix to an antiparallel β-sheet which
can be controlled by changing surface pressure.
3.2. Morphological and structural study of EBO17 and EBO24 inserted into a
lipid monolayer
3.2.1. Study of the morphology and the stability of mixed EBO17 or EBO24
with lipid monolayers
To investigate the changes in morphology and stability induced by
EBO peptides in interaction with the DMPC:DMPG:cholesterol:DMPE
monolayer at the molar ratio 6:2:5:3, we ﬁrst studied the morphology
and the stability of the lipid alone in the surface pressure range from 5
to 30 mN/m. The molecular area of approximately 45 Å2/mol before
collapse obtained from the surface pressure (∏)–area (A) isotherm ofthe lipid monolayer (Fig. 3) is consistent with that of Langmuir mono-
layers mainly composed of phospholipids with dimyristoylacyl chains
[29]. The isotherm is reversible during decompression showing a very
small hysteresis which suggests that there is no loss of material into
the subphase. BAM pictures (Fig. 4, ﬁrst row micrographs) show that
the surface is homogeneous whatever the surface pressure during com-
pression and decompression. Such an observation could be surprising
since the monolayer contains DMPE and cholesterol which display
high phase transition temperatures (N49 °C) compared to DMPC and
DMPG (23 °C), then one can expect to observe segregation of lipids in
the monolayer. Taking into account the large content in cholesterol of
themonolayer, the observation of such a homogeneous ﬁlm can proba-
bly be explained by attractive interactions between the different phos-
pholipids and cholesterol as previously reported [30]. Ellipsometric
measurements and thickness estimations using a refractive index of
1.46 for the lipids (cf. Materials and methods section) lead to 13 ±
1 Å (Δ = 351.01°, Ψ = 2.39°) for the thickness of the lipid mono-
layer at 5 mN/m, 14 ± 1 Å (Δ = 350.45°, Ψ = 2.39°) at 15 mN/m
and 15 ± 1 Å (Δ = 349.98°, Ψ = 2.39°) at 30 mN/m.
BAM pictures and compression isotherms of EBO peptides inserted
into a lipid monolayer are recorded after co-deposition at the air/
water interface of a peptide/lipid (DMPC:DMPG:cholesterol:DMPE
6:2:5:3) mixture at a deﬁned lipid to peptide ratio, Ri = 20 or Ri =
50.When EBOpeptides are inserted into the lipidmonolayer, important
changes in the morphology of the layer are observed compared to the
lipid alone (Fig. 4). At low surface pressure (5 mN/m), whatever the
peptide and the lipid/peptide ratio Ri (20 or 50) very heterogeneous
surfaces are observed which are characterized by ﬂuid circular domains
in a less dense phase (dark background). If at Ri = 50, there is no im-
portant thickness difference between the two phases (14–15 Å for the
denser compared to 12–13 Å), it is noteworthy that at high peptide con-
tent (Ri = 20), themain thickness of the surrounding phase is very low
(b7 Å) as if the peptides lead to a condensation of the material in the
layer. When the surface pressure increases to 15 mN/m, whatever the
peptide and the Ri, there is a homogenization of the surface which ap-
pears to be more rigid compared to the lipid alone with a mean thick-
ness around 13 ± 1 Å. At high surface pressure (30 mN/m), whatever
the peptide and the Ri, pictures are characterized by a bright network
formed by long and thin interconnected ﬁlaments of high thickness
(N18 Å) in a homogeneous phase of 14 ± 1 Å thick. The decompression
down to 15 mN/m leads back to a homogenization of the surfacewhich
appears highly comparable to the lipid alone both in the thickness
(14 ± 1 Å thick) and ﬂuidity. At low surface pressures (5 mN/m),
Fig. 4. BAM images of a lipidmonolayer composed of DMPC:DMPG:cholesterol:DMPE 6:2:5:3 (ﬁrst line),mixedDMPC:DMPG:cholesterol:DMPE (6:2:5:3)/EBO17 at Ri = 20 (second line)
and Ri = 50 (third line) andmixed DMPC:DMPG:cholesterol:DMPE (6:2:5:3)/EBO24 at Ri = 20 (fourth line) and Ri = 50 (last line). Exposition time for each image was ﬁxed at 1/50 s.
Subphase: saline solution, 150 mN NaCl, pH 5.6.
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some heterogeneities remain at Ri = 20 but in both cases, the mean
thickness is close to the one of the lipid monolayer alone (13 ± 1 Å).
Despite these differences, whatever the peptide and the Ri, the changes
observed in morphology during compression are not reversible during
decompression.
An explanation is given by the compression isotherm (Fig. 3) of the
mixed EBO17/lipid monolayer at Ri = 20. Indeed, at the beginning of
the compression (low surface pressures), the molecular area is larger
for the mixed EBO17/lipid monolayer compared to that of the lipid
alone because of the contribution of the peptide. When the molecular
area decreases, the shape of the isotherm is different from that of the
lipid alone (weaker slope) showing the inﬂuence of the peptide. At
high surface pressures (up to 20 mN/m), the isotherm of the mixed
EBO17/lipidmonolayer intersects the one of the lipid alone.We observe
changes of slope in the isothermwhich correspond to stop of compres-
sion at a deﬁned pressure. The observed plateaus demonstrate that it
becomes difﬁcult tomaintain compression levels, showing an instability
of the mixed EBO17/lipid monolayer and the loss of material in the
subphase. The decompression shows an important hysteresis and the
shape of the isotherm is close to the one of the lipid alone. The same be-
havior has been observed whatever the peptide (EBO17 and EBO24)
and whatever the Ri (20 or 50) (data not shown). These results showthat whatever the EBO peptide and the Ri tested, the presence of the
peptide destabilizes the lipid monolayer.
3.2.2. PMIRRAS structure study of mixed EBO17 or EBO 24/lipid monolayers
PMIRRAS spectra of EBO peptides inserted into a DMPC:DMPG:
cholesterol:DMPE (6:2:5:3) lipid monolayer are recorded as previously
described. The mixed monolayer was compressed from 5 to 40 mN/m
then decompressed down to 5 mN/m. PMIRRAS spectra were recorded
at different surface pressures (Fig. 5). Every spectrum shows a band cen-
tered around 1737 cm−1 characteristics of the (C_O) ester stretching
vibration. The δ (CH2) bending vibration of acyl chains at 1467 cm−1
can also be observed on the majority of the spectra except for the
5 mN/m spectrum during compression of EBO17 (Ri = 50) as well as
those at 5 and 15 mN/m (compression) of EBO24 (Ri = 20) where
the band is difﬁcult to distinguish from the noise [31]. Whatever
EBO17 or EBO24 and the lipid ratio Ri = 50 or Ri = 20, the same be-
havior during compression and decompression occurs. At the beginning
of the compression (5 mN/m), a large intensity of the amide I band of
the peptide can be observed, which is consistent with the substantial
Ri. This band is centered at approximately 1653 cm−1, which is a char-
acteristic of a major α-helix folding. The lack or very weak contribution
of the amide II band shows that the helix ismainly orientedwith its axis
parallel to the monolayer. At Ri = 50 mainly on EBO17 spectrum, a
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EBO24, left: Ri = 50, right: Ri = 20. Subphase: saline solution, 150 mN NaCl, pH 5.6.
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tures as it was observed for the peptide alone. As the surface pressure
increases (up to 30 mN/m), the absorption bands of the lipids increases
due to the concentration of the molecules under the beamwhereas the
amide I band of the peptides decreases progressively and sometimes
disappears. To be sure that this phenomenon was not due to an optical
effect, the ratio of the lipid/peptide spectrum towards the spectrum of a
pure lipid monolayer at the same surface pressure was performed and
no amide I band was observed (data not shown). This again demon-
strates the instability of the mixed EBO/lipid monolayer at high surface
pressures and the exclusion of EBO peptide (or EBO peptide/lipid com-
plexes) from the monolayer. During decompression from 40 mN/m
down to 5 mN/m, the amide I band does not appear again (EBO17), or
weakly (EBO24) and the main structure remains α-helical.
3.3. Study of EBO17 and EBO24 peptides inserted into lipid bilayers by ATR
We further investigated the behavior of the peptides inserted into
lipid bilayers (either in a single supported lipid bilayer or in MLV in so-
lution)made of the same lipid mixture DMPC:DMPG:cholesterol:DMPE
(6:2:5:3), these model being closer to natural membranes. We hence
performed polarized ATR experiments in order to analyze the structure
(and the orientation when it is possible) of the fusion peptides in such
membrane models as well as perturbations induced by the peptide on
the organization of the lipids.3.3.1. EBO17 and EBO24 inserted into a single supported lipid bilayer at
Ri = 150 by ATR spectroscopy
The pure lipid ormixed EBO/lipid bilayers adsorbed on a germanium
ATR crystal were obtained by spontaneous fusion of small unilamellar
vesicles (SUV) of pure lipid or mixed EBO/lipid at the deﬁned Ri. Fig. 6A
and B displays the ATR spectra obtained in the 1800–1500 cm−1 region.
The band around 1735 cm−1 corresponds to the (C_O) ester of the
lipids while the 1700–1600 cm−1 domain corresponds to the amide I.
The amide I region was analyzed and the secondary structure content
was evaluated from the analysis of the amide I band shape and curve
ﬁtting [15]. The 1684 ± 1 cm−1, 1633 ± 1 cm−1 and 1623 ± 1 cm−1
bands were assigned to β-sheets, the 1661 cm−1 and 1652 ± 1 cm−1
bands to α-helices, the 1642 ± 2 cm−1 band to random structures and
the 1671 ± 2 cm−1 band to β-turns. The results are presented in
Table 1. It can be seen that with the burst SUV at Ri = 150, EBO17 and
EBO24 display a quite comparable structural compositionwith a predom-
inantα-helical structure (37.7% and 43.0% respectively). Using the p- and
s-polarized spectra, we then estimated the dichroïc ratio of the amide I
band of theα-helix, we obtain RATR (amide I/α-helix) N 2.4 which allows
to estimate that theα-helix ismainly perpendicular to the plane of the bi-
layer [19].
To investigate the consequence of the EBO peptide insertion on the
organization of the lipid acyl chains in the bilayer, the shift of the
bands corresponding to antisymmetric and symmetric stretching
modes of the methylene groups, νs(CH2) and νas(CH2), respectively,
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Fig. 6.ATR spectra in the amide I region of EBO17 and EBO24 inserted into lipid bilayer DMPC:DMPG:cholesterol:DMPE (6:2:5:3) hydrated byD2O + 150 mMNaCl. A: EBO17 at Ri = 150
in a supported lipid bilayer: isotropic spectrum (solid line), p-polarized spectrum (dotted line), s-polarized spectrum (dashed line), B: EBO24 at Ri = 150 in a supported lipid bilayer:
isotropic spectrum (solid line), p-polarized spectrum (dotted line), s-polarized spectrum (dashed line), C: EBO17 (solid line) and EBO24 (dotted line) in MLV Ri = 100, D: EBO17
(solid line) and EBO24 (dotted line) in MLV Ri = 20.
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known to be sensitive to changes in the conﬁguration of the acyl chains,
in chain mobility and packing [32–35]. The νs(CH2) and νas(CH2) of
2851.7 and 2920.7 cm−1 respectively for the bilayer alone are charac-
teristic of quite well ordered acyl chains, which is consistent with a bi-
layer composed of phospholipids with phase transition temperature
higher than 23 °C. When EBO peptides interact with the bilayer, there
is an average decrease of 1.6 ± 0.3 cm−1 in the wavenumbers of the
νs(CH2) and νas(CH2) which shows an increase of the chains order
due to the EBO peptide insertion (Fig. 7, Table 2). This is conﬁrmed byTable 1
Wavenumbers and secondary structure contents for EBO17 and EBO24 in different lipid enviro
by ﬁt of the ATR-IR spectra in the amide I region. Lipid composition: DMPC:DMPG:cholesterol:
EBO17
Secondary structure Wavenumber
(cm−1)
In supported bilayer Ri = 150 β-sheet 1625–1632–1684
Random 1644
α-helix 1652–1661
β-turn 1673
In MLV Ri = 100 β-sheet 1625–1685
Random 1641
α-helix 1655–1661
β-turn 1675
In MLV Ri = 20 β-sheet 1624–1683
Random 1640
α-helix 1655
β-turn 1673the evolution of the dichroïc ratio (RATR) of the νs(CH2) band of lipid
chains which was measured on the polarized ATR spectra (Table 2). In-
deed, since the transition moment for the νs(CH2) lies perpendicular to
the chain axis, the introduction of order or disorder alters the direction
of the main chain with respect to the normal of the ATR crystal. The di-
chroïc ratio is then expected to provide a sensitive and quantitative in-
dicator of acyl chain order by estimating the average C\C\C angle of
the lipid carbon chains with the normal to the interface [19]. Here, the
RATR decreases when EBO peptides interact with the lipids, compared
to the lipid alone (Table 2). This corresponds to a reorientation of thenments (supported lipid bilayer or MLV) and at different lipid/peptide ratios (Ri) obtained
DMPE (6:2:5:3).
EBO24
%
(±2.5)
Secondary structure Wavenumber
(cm−1)
%
(±2.5)
28.1 β-sheet 1622–1633–1683 24.4
20.0 Random 1641 22.2
37.7 a-helix 1653 43.0
14.2 β-turn 1670 13.4
31.4 β-sheet 1625–1631–1685 38.8
23.5 Random 1642 24.8
34.5 α-helix 1654–1662 28.8
10.8 β-turn 1673 7.6
39.1 β-sheet 1626–1683 50.0
21.6 Random 1640 26.0
30.5 α-helix 1651 11.0
8.8 β-turn 1670 13.0
Table 2
Wavenumbers and dichroïc ratio of νas (CH2) and νs (CH2) of lipid chains and dichroïc ratio of ν(C_O) ester band around 1735 cm−1 in the absence and in the presence of EBO peptides.
Lipid composition: DMPC:DMPG:cholesterol:DMPE (6:2:5:3).
νas(CH2)
(cm−1)
νs(CH2)
(cm−1)
RATR
(νs(CH2))
RATR (ν(C_O))
Supported lipid bilayer Alone 2920.7 ± 0,4 2851.7 ± 0,3 1.34 ± 0,05 1.67 ± 0,05
+EBO17−Ri = 150 2918.9 ± 0,4 2850.4 ± 0,3 1.24 ± 0,05 1.95 ± 0,05
+EBO24−Ri = 150 2919.4 ± 0,4 2850.8 ± 0,3 1.17 ± 0,05 2.07 ± 0,05
MLV Alone 2920.1 ± 0,4 2851.0 ± 0,3 – –
+EBO17−Ri = 100 2919.7 ± 0,5 2850.3 ± 0,1 – –
+EBO24−Ri = 100 2918.5 ± 0,6 2850.3 ± 0,3 – –
+EBO17−Ri = 20 2921.8 ± 0,5 2852.9 ± 0,3 – –
+EBO24−Ri = 20 2921.9 ± 0,6 2853.4 ± 0,3 – –
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lipid alone to 35–40° in the presence of EBO peptides [19]. Conversely,
the dichroïc ratio of the ν(C_O) ester band of the lipids increases
from 1.67 for the lipid alone to around 2.00 in the presence of the EBO
peptide which is a characteristic of an increase of disorder. Altogether,
this experiment is showing that whatever the EBO peptide, its insertion
as amainly verticalα-helix into the lipid bilayer at Ri = 150 leads to an
increase of the order of the acyl chains but disorganizes the glycerol re-
gion of the lipids.
3.3.2. EBO17 and EBO24 inserted into multilamellar vesicles (MLV) at
Ri = 100 and Ri = 20 by ATR spectroscopy
A single lipid bilayer could not be obtained using SUV bursting on
the Ge crystal surface with the largest peptide content (Ri = 20) most
likely because of the resulting SUV destabilization by the peptide. Con-
sequently, EBO peptides have been incorporated in MLV using the
same lipid mixture and ATR spectra have been recorded in solution
(Fig. 6C and D), which allowed to estimate the peptide secondary struc-
ture content by ﬁtting the amide I band (Table 1).
To compare with the results obtained with a single lipid bilayer at
Ri = 150, MLV were ﬁrst used at a lipid to peptide ratio of 100. The
amide I region of spectra (Fig. 6C) was analyzed and the secondary
structure content of the peptide bound to theseMLVhas then been eval-
uated from the analysis of the amide I band shape and curve ﬁtting [15]
(Table 1). It can be seen that the increase of the peptide content (Ri =
100) in MLV leads to an increase of the β-sheet content at the expense
of the α-helical structure. The α-helix to β-sheet conversion is larger
for the EBO24 peptide compared to the EBO17 peptide: +14.4% of
β-sheets and −14.2% of α-helices for EBO24 compared to +3.3% of0
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Fig. 7. ATR spectra in the 3000–2800 cm−1 region of a supported lipid bilayer DMPC:
DMPG:cholesterol:DMPE (6:2:5:3) hydrated by D2O + 150 mM NaCl: alone (solid line),
+EBO17 Ri = 150 (dotted line), +EBO24 Ri = 150 (dotted line).β-sheets and −3.2% of α-helices for EBO17. On EBO24, the β-sheet
structure becomes predominant at Ri = 100 in MLV. Concerning lipid
chain perturbation on MLV (Table 2), the same phenomenon is ob-
served compared to the single bilayer at Ri = 150: there is an average
decrease of −1.0 cm−1 and −0.7 cm−1 in the wavenumbers of the
νas(CH2) and νs(CH2) respectively which suggests that the acyl chain
order increased as a result of the EBO peptide insertion (Table 2).
At high peptide concentration (Ri = 20), a large increase of the
β-sheet content can be observed both for EBO17 (39.1%) and for
EBO24 (50.0%) compared to what has been obtained at Ri = 150 with
the burst SUV or at Ri = 100 for the MLV (Fig. 6D, Table 1). Conversely,
the α-helix content decreases while the random and β-turn contents
remain comparable.We also investigated that the perturbation induced
to the lipids upon EBO peptide binding has also been investigated by
measuring the shift of νs(CH2) and νas(CH2) (Table 2). Whatever the
EBO peptide at Ri = 20, a shift to higher wavenumber has been ob-
served for νs(CH2) and νas(CH2) (+1.4 cm−1 for νas(CH2), +1.9 to
2.4 cm−1 for νs(CH2)) in the presence of EBO peptides compared to
the MLV alone which shows an increase of the chain disorder due to
the EBO peptide insertion.
4. Discussion
4.1. Reversible conformational changes of EBO peptides
The IR results presented here show the structural polymorphism of
the EBO peptides (EBO17 and EBO24) and their ability to change their
conformation from anα-helix to antiparallel β-sheets. Such a transition
occurs for the peptides alone at the air/water interface due to surface
pressure increase as well as for the peptides inserted in lipid bilayers
(single supported bilayer or MLV) due to the increase of the peptide
concentration in the lipid system (Ri = 150 to Ri = 20). We can
point out that as the surface pressure increases at the air/water inter-
face, peptide surface density increases and so the concentration. There-
fore, this α-to-β structural transition occurs with increasing peptide
concentration. The comparable structural behavior of EBO17 and
EBO24 shows that all the information required for this structural plastic-
ity is contained in the17 amino-acid sequence. As observed in our struc-
tural data (PMIRRAS and ATR), the lengthening of the sequence only
allows to achieve structural folding at lower constraints (lower surface
pressure and lower Ri). The ability of EBO17 to exist as an α-helix or
as β-sheets was previously observed in a study where the authors
showed a calcium dependent conformational change [7]. More general-
ly, this ability to exist in these two structural states, or to modify their
structure from an α-helix to antiparallel β-sheets seems to be a com-
mon behavior for several viral fusion peptides, as it was also observed
for other class I fusion peptides such as FP23 fusion peptide of HIV-1
gp41 [19,36] and PIV5 fusion peptide of the Paramyxovirus [37] or the
inﬂuenza hemagglutinin fusion peptide [38].
Such a common behavior can probably be explained by shared
sequence characteristics like their enrichment in G and A residues
(around 15% and 30% of amino-acid in their sequence respectively) at
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even if class I fusion peptides display some sequence similarities, the
present data are showing that this conformational change can be
reversible since a reverse transition was observed from antiparallel
β-sheet to mainly α-helices upon surface pressure decrease of the
monolayer. This reversible shift between α-helical and β-sheet struc-
ture was not observed for FP23 fusion peptide of HIV in the same time
scale of experiments [19] but was observed for the ﬁrst time with
completely different peptide sequences involved in the intracellular
membrane fusion of vesicles. Indeed, this α-helix to β-sheet conforma-
tional change was also observed in the transmembrane domain of
SNARE proteins, VAMPTM22 from VAMP1 and SYNTM23 from Syntaxin 1
depending on the lipid to peptide ratio [40]. These results illustrate
some remarkable similarities on structural properties shared by totally
different fusion processes such as class I viral fusion and intracellular
fusion.
Actually, numerous studies demonstrate that a delicate balance be-
tween α and β structures, essential for protein-mediated viral mem-
brane fusion is inﬂuenced by environmental conditions such as pH
and ionic strength [41], the peptide sequence, presence or absence of di-
valent cations [7], the cholesterol content [36] and by the lipid/peptide
ratio [36,42,43]. In the present study, we show that the conformational
transition from an α-helix to a β-sheet is induced by a change in the
peptide to lipid ratio in the membrane even in absence of calcium con-
trary towhat Suarez and colleagues had previously suggested for EBO17
[7]. In our case, at low peptide concentration in lipids, EBO peptides
(EBO17 and EBO24) interact with lipids mainly as α-helices. As the
local peptide concentration increases in the membrane, the proportion
of α-helix drops off in favor of a mainly antiparallel β-sheet structure.
The formation of antiparallel β-sheet structure is probably due to the
association of the peptides allowed by the close contacts induced by in-
creasing concentration. This concentration dependent effect on peptide
conformation might be of biological relevance. In the case of Ebola, ex-
periments were made with a lipid to peptide ratio which potentially
mimic the local concentrations of the peptide at the beginning of its in-
sertion in the host membrane (Ri = 150 and Ri = 100) and its local
gathering (Ri = 20) since several trimers of GP2 are thought to be in-
volved in the fusion mechanism [44]. One can assume that during the
fusion event, the Ebola fusion peptide inserts in the host membrane as
anα-helix and then changes its conformation to amainlyβ-sheet struc-
ture as its local concentration in themembrane increases, this structural
plasticity being essential for the destabilization and lipid mixing taking
place during membrane fusion processes [45,46]. Ebola GP shares gen-
eral features with many other viral membrane fusion proteins. The
more extensively studied HA1 and HA2 subunits from inﬂuenza virus
are respectively analogous to the Ebola GP1 andGP2 subunits. Ebola gly-
coprotein GP2, like HA2, forms long trimeric coiled coils of α-helices
(N-terminal α-helices) surrounded by a second layer of three shorter
α-helices (C-terminal α-helices), creating a six helix-bundle in the
late stage of fusion [47,48]. Although there is no direct evidence that
the fusion peptide itself interacts with the C-terminal helices of GP2,
its structural plasticity together with the reversibility of its structure
could be of particular signiﬁcance at this stage of the viral fusion.
4.2. Effect of EBO peptides on the lipid membrane organization
Our FTIR results suggest that, at low peptide content (Ri N 100), EBO
peptides predominantly insert as α-helices oriented perpendicular to
the plane of the lipid bilayer, which results in an increase of the order
of the acyl chains of the lipids and a simultaneous destabilization of
the lipid head groups. Although it is often difﬁcult to properly compare
experimental conditions and molecular modeling experiments in the
determination of peptide orientation, the present result of a perpendic-
ular orientation of the α-helical structure of the EBO peptides with re-
spect to the plane of the membrane differs from that reported by
Adam et al. [13]. Indeed, using molecular modeling, they found thatthemost stable orientation of a shorter EBO fusion peptide (ﬁrst 11 res-
idues of present EBO sequence) was 47° with respect the membrane
plane. The effect of lipid chains increased order is in agreement with
what was found by Gray and colleagues [38] who demonstrated that
the lipid order parameter increaseswhen the fusion peptide of hemagglu-
tinin of inﬂuenza virus was incorporated into the bilayer at a lipid to pep-
tide ratio of ~Ri = 150. One can speculate that this result may be related
both to the high content ofmainly vertically orientedα-helixwhich could
organize the adjacent lipid chains by hydrophobic interactions and to the
rearrangement ofwatermolecules at themembrane interface in response
to the binding of fusion peptides. Indeed, dehydration at the surface is
known to increase the phase transition temperature in pure lipid bilayers
[49]which is equivalent to an increase of the order of hydrocarbon chains
in the hydrophobic core of lipid bilayers.
PMIRRAS and ATR data show that important perturbations of the
lipid organization both in mono- and bilayer occur when the peptide
concentration in the membrane was increased up to Ri = 20.
PMIRRAS and Langmuir data showed that EBO peptide insertion leads
to an important destabilization of the lipid monolayer, which results
in to a loss of both lipids and peptides into the subphase during com-
pression, presumably because of the disordering of the lipid monolayer
by the EBO peptides. ATRdata also showed that EBO peptide insertion at
Ri = 20 leads to an important disorder in the lipid chain organization in
the MLV bilayers. These results could allow to explain the impossibility
to prepare SUV using mixtures of lipids and EBO peptides with at high
peptide content. The ability of such fusion peptide to induce lipid
chain disorder has previously been demonstrated for inﬂuenza fusion
peptides where a change in membrane curvature was observed due to
their ability to induce non bilayer lipid phases [50,51] for FP23 of HIV
[19,52] as well as for FP of PIV5 where the β-sheet conformation
promotes signiﬁcant membrane curvature [37]. This common ability
of fusion peptides to promote negative curvature, to lower the rupture
tension of the lipid layers and to favor the formation of inverted phases
is thought to be associated with initial steps of membrane fusion [53].
The present study shows the structural polymorphism of Ebola fusion
peptide and demonstrates its ability to transit reversibly from a mainly
α-helical structure to antiparallel β-sheets leading to a destabilization at
large scale of the lipid membrane. As this structural ﬂexibility is shared
by different fusion processes (viral fusion, intracellular fusion), it could
play a key role in the fusionmechanism. Therefore, itwould be interesting
to follow such type of fundamental study to get a complete understanding
of interactions between fusion peptides and membranes.
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